Trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer with brain metastases: A subgroup analysis of the DESTINY-Breast01 trial Meeting Abstract
| Authors: | Jerusalem, G. H. M.; Park, Y. H.; Yamashita, T.; Hurvitz, S. A.; Modi, S.; Andre, F.; Krop, I. E.; Gonzalez, X.; Hall, P. S.; You, B.; Saura, C.; Kim, S. B.; Osborne, C. R. C.; Sagara, Y.; Tokunaga, E.; Liu, Y.; Cathcart, J.; Lee, C. C.; Perrin, C. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer with brain metastases: A subgroup analysis of the DESTINY-Breast01 trial |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120600038 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.526 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 526 -- Source: Wos |
